Rituximab
Response
No. of Patients (%)
Total (n = 43)
Rituximab (n = 26
)
†
Chemoimmunotherapy
(n = 6
)
‡
Chemotherapy (n = 11)
CR
8 (31)
1 (17)
2 (18)
11 (26)
Cru
3 (12)
1 (17)
0
4 (9)
PR
12 (46)
3 (50)
4 (36)
19 (44)
CR, CRu, and PR
23 (88)
5 (83)
6 (55)
34 (79)
Tsimberidou et al. 2006
1338 / 1498
